127 related articles for article (PubMed ID: 37278090)
1. Understanding the Mechanism and Extent of Transplacental Transfer of (-)-∆
Kumar AR; Sheikh ED; Monson JW; Ligon SE; Talley RL; Dornisch EM; Howitz KJ; Damicis JR; Ieronimakis N; Unadkat JD
Clin Pharmacol Ther; 2023 Aug; 114(2):446-458. PubMed ID: 37278090
[TBL] [Abstract][Full Text] [Related]
2. Maternal and Fetal Exposure to (-)-Δ
Chen X; Unadkat JD; Mao Q
Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2).
Chen X; Unadkat JD; Mao Q
Drug Metab Dispos; 2021 Oct; 49(10):910-918. PubMed ID: 34326138
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
Peng J; Ladumor MK; Unadkat JD
Drug Metab Dispos; 2022 May; 50(5):613-623. PubMed ID: 35149540
[TBL] [Abstract][Full Text] [Related]
5. Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Vinot C; Gavard L; Tréluyer JM; Manceau S; Courbon E; Scherrmann JM; Declèves X; Duro D; Peytavin G; Mandelbrot L; Giraud C
Antimicrob Agents Chemother; 2013 Mar; 57(3):1415-20. PubMed ID: 23295922
[TBL] [Abstract][Full Text] [Related]
6. Successful Prediction of Fetal Exposure to Dual BCRP/P-gp Drug Substrates Using the Efflux Ratio-Relative Expression Factor Approach and PBPK M&S.
Balhara A; Yin M; Unadkat JD
Clin Pharmacol Ther; 2024 May; 115(5):1044-1053. PubMed ID: 38124355
[TBL] [Abstract][Full Text] [Related]
7. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
Han LW; Gao C; Mao Q
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methods.
Cerveny L; Karbanova S; Karahoda R; Horackova H; Jiraskova L; Ali MNH; Staud F
Toxicol Appl Pharmacol; 2023 Mar; 463():116427. PubMed ID: 36801311
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.
Sudhakaran S; Rayner CR; Li J; Kong DC; Gude NM; Nation RL
Br J Clin Pharmacol; 2008 May; 65(5):667-73. PubMed ID: 18093255
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
[TBL] [Abstract][Full Text] [Related]
11. Transplacental transfer of nitrosodimethylamine in perfused human placenta.
Annola K; Heikkinen AT; Partanen H; Woodhouse H; Segerbäck D; Vähäkangas K
Placenta; 2009 Mar; 30(3):277-83. PubMed ID: 19215982
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 expression is increased in human first trimester placenta from pregnant women classified as overweight or obese.
Justesen S; Bilde K; Olesen RH; Pedersen LH; Ernst E; Larsen A
Sci Rep; 2023 Mar; 13(1):5175. PubMed ID: 36997557
[TBL] [Abstract][Full Text] [Related]
13. Transplacental Pharmacokinetic Model of Digoxin Based on Ex Vivo Human Placental Perfusion Study.
Kurosawa K; Noguchi S; Nishimura T; Tomi M; Chiba K
Drug Metab Dispos; 2022 Mar; 50(3):287-298. PubMed ID: 34903589
[TBL] [Abstract][Full Text] [Related]
14. Successful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and Simulation.
Anoshchenko O; Storelli F; Unadkat JD
Drug Metab Dispos; 2021 Oct; 49(10):919-928. PubMed ID: 34426410
[TBL] [Abstract][Full Text] [Related]
15. P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine.
Liao MZ; Gao C; Shireman LM; Phillips B; Risler LJ; Neradugomma NK; Choudhari P; Prasad B; Shen DD; Mao Q
Pharmacol Res; 2017 May; 119():61-71. PubMed ID: 28111265
[TBL] [Abstract][Full Text] [Related]
16. Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics.
Tupova L; Ceckova M; Ambrus C; Sorf A; Ptackova Z; Gaborik Z; Staud F
Drug Metab Dispos; 2019 Sep; 47(9):954-960. PubMed ID: 31266750
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
Feinshtein V; Erez O; Ben-Zvi Z; Eshkoli T; Sheizaf B; Sheiner E; Holcberg G
Am J Obstet Gynecol; 2013 Dec; 209(6):573.e1-573.e15. PubMed ID: 23933222
[TBL] [Abstract][Full Text] [Related]
18. Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure ? Placental transfer across the perfused human placenta.
Grandin FC; Lacroix MZ; Gayrard V; Viguié C; Mila H; de Place A; Vayssière C; Morin M; Corbett J; Gayrard C; Gely CA; Toutain PL; Picard-Hagen N
Chemosphere; 2019 Apr; 221():471-478. PubMed ID: 30654261
[TBL] [Abstract][Full Text] [Related]
19. Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice.
Spiro AS; Wong A; Boucher AA; Arnold JC
PLoS One; 2012; 7(4):e35937. PubMed ID: 22536451
[TBL] [Abstract][Full Text] [Related]
20. Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism.
Immonen E; Kummu M; Petsalo A; Pihlaja T; Mathiesen L; Nielsen JK; Knudsen LE; Vähäkangas K; Myllynen P
Placenta; 2010 Jul; 31(7):641-8. PubMed ID: 20570348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
